Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
about
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependenceRapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of theBaseline characteristics of patients predicting suitability for rapid naltrexone induction.The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.Decreased injecting is associated with increased alcohol consumption among injecting drug users in northern Vietnam.Naltrexone: Not Just for Opioids AnymorePrescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.Clonidine inhibits anti-non-Gal IgM xenoantibody elicited in multiple pig-to-primate models.Pharmacotherapies for treating opioid use disorder.Opioid maintenance, weaning and detoxification techniques: where we have been, where we are now and what the future holds.Medication-assisted treatment for substance use disorders within a national community health center research network.NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.Medications for substance use disorders (SUD): emerging approaches.Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
P2860
Q33556479-CF347AEC-2F2B-4B97-8BD7-6E3BD1896C17Q33595868-D7FB8CDC-6C75-46BB-A1AB-78D8E5652958Q33783250-A55B02E4-ED70-43AA-B94B-DC80517F22D3Q34371727-D9D8C47B-55E8-4EEB-B665-812E0516848FQ35834292-6D596D03-D260-40B6-9D04-BC3E92606761Q35952033-C8C22D56-23CE-4B6D-944D-4E35B659E2CEQ36639092-ABACE48E-1EB7-49DE-B2E1-2B1C520B9FF2Q36660846-C6763CD2-E737-4AB3-B72D-3DD5707DCA9BQ36664176-397DF68F-2D20-4E02-BE84-17951FDAD7CEQ36992735-2851EA03-ABFA-424B-BFCE-271F1C8CDCDDQ38096571-CDED7C88-F1CB-4BD6-BAFA-F3B5BFCF42A2Q39225935-B880F63D-6C3B-44FD-B3A6-60211C8E1B17Q39740604-1F271CC5-5A30-4658-9A41-94D2E16A523AQ42289728-C151ACB4-B30C-41A5-80F3-A893A5EFB182Q43061611-E60B7866-34B6-4ED7-A2A1-F05654DF47CBQ44333905-7EB89EC5-4339-4E8D-B3B6-FA965B23E30DQ44342511-AE4E4731-8F1F-4C99-B4C5-563F62223FCAQ47731975-B8D4C15C-923B-4B0D-AA74-AB96C0D42DB5Q48351988-8F627503-33D0-4327-901B-05FD28A45B95Q52317035-9B922A90-9EF3-4C36-A28B-4EDE44363994
P2860
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Opioid detoxification and nalt ...... dations for clinical practice.
@ast
Opioid detoxification and nalt ...... dations for clinical practice.
@en
type
label
Opioid detoxification and nalt ...... dations for clinical practice.
@ast
Opioid detoxification and nalt ...... dations for clinical practice.
@en
prefLabel
Opioid detoxification and nalt ...... dations for clinical practice.
@ast
Opioid detoxification and nalt ...... dations for clinical practice.
@en
P2093
P2860
P1476
Opioid detoxification and nalt ...... dations for clinical practice.
@en
P2093
Edward V Nunes
George Woody
Patrick G O'Connor
Stacey C Sigmon
Thomas Kosten
P2860
P304
P356
10.3109/00952990.2011.653426
P50
P577
2012-03-12T00:00:00Z